Acasă › Cancer de sân › Connecticut › Bridgeport
Studii clinice pentru Cancer de sân în Bridgeport, CT
21 studii pentru Cancer de sân caută participanți în și în jurul orașului Bridgeport (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Stony Brook University Medical Center, Stony Brook · La 18 mi distanță
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
În curs de recrutareFaza 3
- Stony Brook University-Cancer Center ( Site 0034), Stony Brook · La 18 mi distanță
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
În curs de recrutareFaza 3
- Research Site, Stony Brook · La 18 mi distanță
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
În curs de recrutareFaza 3
- Smilow Cancer Hospital Care Center - Trumbull, Trumbull · La 4 mi distanță
- Smilow Cancer Hospital Care Center - Fairfield, Fairfield · La 5 mi distanță
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
În curs de recrutare
- Stony Brook Cancer Center, Stony Brook · La 18 mi distanță
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
În curs de recrutareFaza 1/2
- Stony Brook University Hospital, Stony Brook · La 18 mi distanță
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
În curs de recrutareFaza 3
- Stony Brook University Medical Center, Stony Brook · La 18 mi distanță
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
În curs de recrutareFaza 3
- Stony Brook University Cancer Center, Stony Brook · La 18 mi distanță
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
În curs de recrutareFaza 3
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C. (Port Jefferson Station2), Port Jefferson Station · La 19 mi distanță
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C.(Port Jefferson Station1), Port Jefferson Station · La 19 mi distanță
- New York Cancers & Blood Specialists, Port Jefferson Station · La 19 mi distanță
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
În curs de recrutareFaza 3
- Hartford HealthCare - Saint Vincent's Medical Center, Bridgeport
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · La 4 mi distanță
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · La 5 mi distanță
- și încă 1
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
În curs de recrutareFaza 2
- Stony Brook Cancer Center, Stony Brook · La 18 mi distanță
ATEMPT 2.0: Adjuvant T-DM1 vs TH
În curs de recrutareFaza 2
- Smilow Cancer Hospital Care center at Trumbull, Trumbull · La 4 mi distanță
- Smilow Cancer Hospital Care center at Fairfield, Fairfield · La 5 mi distanță
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
În curs de recrutareFaza 1
- New York Cancer and Blood Specialists, Port Jefferson Station · La 19 mi distanță
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
În curs de recrutareFaza 3
- Stony Brook University Cancer Center, Stony Brook · La 18 mi distanță
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
În curs de recrutareFaza 3
- Smilow Cancer Hospital - Fairfield, Fairfield · La 5 mi distanță
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
În curs de recrutareFaza 3
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · La 4 mi distanță
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · La 5 mi distanță
- Stony Brook University Medical Center, Stony Brook · La 18 mi distanță
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
În curs de recrutareStudiu observațional
- Stony Brook Medicine, Stony Brook · La 18 mi distanță
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
În curs de recrutareFaza 1 timpurie
- Stony Brook Breast Center, Stony Brook · La 18 mi distanță
Definitive Radiation Therapy for Inoperable Breast Cancer
În curs de recrutare
- Stony Brook University Cancer Center, Stony Brook · La 18 mi distanță
Definitive Radiation for High-Risk Spine Metastases
În curs de recrutareFaza 2
- Stony Brook University Hospital, Stony Brook · La 18 mi distanță
CtDNA Based MRD Testing for NAC Monitoring in TNBC
În curs de recrutareStudiu observațional
- Stony Brook University Cancer Center, Stony Brook · La 18 mi distanță
Studii pentru Cancer de sân în alte orașe
- New York City, NY136 studii
- Houston, TX126 studii
- Boston, MA112 studii
- Nashville, TN81 studii
- Los Angeles, CA73 studii
- Edison, NJ68 studii
- St. Louis, MO64 studii
- Queens, NY64 studii
- Durham, NC64 studii
- Chicago, IL59 studii
- Philadelphia, PA56 studii
- Dallas, TX55 studii
Alte studii în Bridgeport
- Cancer pulmonar cu celule non-pătrate14 studii
- Cancer pulmonar13 studii
- Leucemie mieloasă acută12 studii
- Boli cardiovasculare9 studii
- Cancer (toate tipurile)8 studii
- Carcinom cu celule scuamoase de cap și gât8 studii
- Cancer metastatic7 studii
- Insuficiență cardiacă7 studii
- Aneurism cerebral6 studii
- Mielom multiplu6 studii
- Cancer de prostată6 studii
- Cancer ovarian5 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.